Literature DB >> 33588306

The role of dectin-1 in health and disease.

Namarta Kalia1, Jatinder Singh2, Manpreet Kaur3.   

Abstract

Dendritic cell-associated C-type lectin-1 (Dectin-1), also known as β-glucan receptor is an emerging pattern recognition receptor (PRR) which belongs to the family of C-type lectin receptor (CLR). This CLR identifies ligands independently of Ca2+ and is majorly involved in coupling of innate with adaptive immunity. Formerly, Dectin-1 was best known for its role in anti-fungal defense only. However, recent explorations suggested its wider role in defense against variety of infectious diseases caused by pathogens including bacteria, parasites and viruses. In fact, Dectin-1 signaling axis has been suggested to be targeted as an effective therapeutic strategy for cancers. Dectin-1 has also been elucidated ascetically in the heart, respiratory, intestinal, neurological and developmental disorders. Being a defensive PRR, Dectin-1 results in optimal immune responses in collaboration with other PRRs, but the overall evaluation reinforces the hypothesis of disease development on dis-regulation of Dectin-1 activity. This underscores the impact of Dectin-1 polymorphisms in modulating protein expression and generation of non-optimal immune responses through defective collaborations, further underlining their therapeutic potential. To add on, Dectin-1 influence autoimmunity and severe inflammation accredited to recognition of self T cells and apoptotic cells through unknown ligands. Few reports have also testified its redundant role in infections, which makes it a complicated molecule to be fully resolved. Thus, Dectin-1 is a hub that runs a complex collaborative network, whose interactive wire connections to different PRRs are still pending to be revealed. Alternatively, so far focus of almost all the researchers was the two major cell surface isoforms of Dectin-1, despite the fact that its soluble functional intracellular isoform (Dectin-1E) has already been dissected but is indefinable. Therefore, this review intensely recommends the need of future research to resolve the un-resolved and treasure the comprehensive role of Dectin-1 in different clinical outcomes, before determining its therapeutic prospective.
Copyright © 2021 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Auto-immune disorders; CLEC7A; Dectin-1; Infectious diseases; Inflammation; Intracellular signaling; Single nucleotide polymorphisms (SNPs)

Mesh:

Substances:

Year:  2021        PMID: 33588306     DOI: 10.1016/j.imbio.2021.152071

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  13 in total

1.  Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation.

Authors:  Min-Xiu Wang; Wu Luo; Lin Ye; Lei-Ming Jin; Bin Yang; Qian-Hui Zhang; Jian-Chang Qian; Yi Wang; Yi Zhang; Guang Liang
Journal:  Acta Pharmacol Sin       Date:  2022-06-10       Impact factor: 6.150

2.  Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic response of dendritic cells after receptor engagement.

Authors:  Carmela Gallo; Emiliano Manzo; Giusi Barra; Laura Fioretto; Marcello Ziaco; Genoveffa Nuzzo; Giuliana d'Ippolito; Francesca Ferrera; Paola Contini; Daniela Castiglia; Claudia Angelini; Raffaele De Palma; Angelo Fontana
Journal:  Cell Mol Life Sci       Date:  2022-06-20       Impact factor: 9.207

3.  Circulating 1,3-Beta-D-Glucan is Associated with Lung Function, Respiratory Symptoms, and Mediators of Matrix Degradation in Chronic Obstructive Pulmonary Disease.

Authors:  Matthew Gorgone; Deepti Singhvi; Seyed Mehdi Nouraie; Malcolm Finkelman; Yonglong Zhang; Jiantao Pu; Divay Chandra; Yingze Zhang; Georgios D Kitsios; Alison Morris; Frank C Sciurba; Jessica Bon
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

4.  Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study.

Authors:  Amer Toutonji; Mamatha Mandava; Silvia Guglietta; Stephen Tomlinson
Journal:  Acta Neuropathol Commun       Date:  2021-07-19       Impact factor: 7.578

Review 5.  Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.

Authors:  Valeria da Costa; Teresa Freire
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

Review 6.  Fungal Colonization and Infections-Interactions with Other Human Diseases.

Authors:  Shanmuga S Mahalingam; Sangeetha Jayaraman; Pushpa Pandiyan
Journal:  Pathogens       Date:  2022-02-06

Review 7.  Dectin-1 Signaling Update: New Perspectives for Trained Immunity.

Authors:  Pablo Mata-Martínez; Marta Bergón-Gutiérrez; Carlos Del Fresno
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

8.  β-Glucans from Trametes versicolor (L.) Lloyd Is Effective for Prevention of Influenza Virus Infection.

Authors:  Shaohua Shi; Lei Yin; Xuehuai Shen; Yin Dai; Jieru Wang; Dongdong Yin; Danjun Zhang; Xiaocheng Pan
Journal:  Viruses       Date:  2022-01-25       Impact factor: 5.048

9.  Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.

Authors:  Fiorella Iglesias Cardenas; Audrey Mauguen; Irene Y Cheung; Kim Kramer; Brian H Kushner; Govind Ragupathi; Nai-Kong V Cheung; Shakeel Modak
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

10.  Vector and Host C-Type Lectin Receptor (CLR)-Fc Fusion Proteins as a Cross-Species Comparative Approach to Screen for CLR-Rift Valley Fever Virus Interactions.

Authors:  Kathleen Schön; Dimitri L Lindenwald; João T Monteiro; Julien Glanz; Klaus Jung; Stefanie C Becker; Bernd Lepenies
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.